The Journal of Nutritional Biochemistry
Volume 18, Issue 2 , Pages 75-85 , February 2007

Mercury as a risk factor for cardiovascular diseases

  • Jyrki K. Virtanen

      Affiliations

    • Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
    • Corresponding Author InformationCorresponding reviewer. Fax: +358 17 162936.
    • ,
  • Tiina H. Rissanen

      Affiliations

    • Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
    • School of Public Health and Clinical Nutrition, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
    • ,
  • Sari Voutilainen

      Affiliations

    • Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
    • ,
  • Tomi-Pekka Tuomainen

      Affiliations

    • Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
    • Unit of Environmental Epidemiology, National Public Health Institute, PO Box 95, 70701 Kuopio, Finland

Received 21 November 2005 ,Revised 6 April 2006 ,Accepted 3 May 2006.

References 

  1. Kris-Etherton PM, Harris WS, Appel LJ for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757
  2. Clarkson TW. The three modern faces of mercury. Environ Health Perspect. 2002;110(Suppl. 1):11–23
  3. Water quality criterion for the protection of human health: methyl mercury. Washington (DC, USA): Environmental Protection Agency; 2001;
  4. Venalainen E-R, Hallikainen A, Parmanne R, Vuorinen PJ. Heavy metal contents in Finnish sea and water fish. National Food Agency of Finland. Available at http://www.palvelu.fi/evi/files/55_519_301.pdf
  5. Mercury levels in commercial fish and shellfish. US Department of Health and Human Services and US Environmental Protection Agency. Updated February 2006; accessed March 2006; available at: http://www.cfsan.fda.gov/~frf/sea-mehg.html2001;
  6. Castoldi AF, Coccini T, Manzo L. Neurotoxic and molecular effects of methylmercury in humans. Rev Environ Health. 2003;18:19–31
  7. International Programme on Chemical Safety (IPCS) . Environmental health criteria 101: methylmercury. Geneva (Switzerland): World Health Organization; 1990;
  8. National Research Council. Toxicological effects of methylmercury. Washington (DC): National Academy Press; 2000;
  9. Mercury study report to Congress. Washington (DC): Environmental Protection Agency; 1997;
  10. What you need to know about mercury in fish and shellfish. US Food and Drug Administration and US Environmental Protection Agency. Accessed March 2006; available at http://www.epa.gov/waterscience/fishadvice/advice.html2004;
  11. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148:265–273
  12. Salonen JT, Seppanen K, Nyyssonen K, Korpela H, Kauhanen J, Kantola M, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91:645–655
  13. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, Korhonen MJ, et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol. 2005;25:228–233
  14. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode A, Gomez-Aracena J, Kark JD, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347:1747N–1754N
  15. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20:46–50
  16. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation. 2000;102:2677–2679
  17. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med. 2002;347:1755–1760
  18. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, Schutz A, et al. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr. 2001;86:397–404
  19. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241
  20. Raymond LJ, Ralston NVC. Mercury: selenium interactions and health implications. Seychelles Med Dental J. 2004;7:72–77
  21. Ganther HE, Goudie C, Sunde ML, Kopecky MJ, Wagner P. Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science. 1972;175:1122–1124
  22. Kosta L, Byrne AR, Zelenko V. Correlation between selenium and mercury in man following exposure to inorganic mercury. Nature. 1975;254:238–239
  23. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev. 2000;52:113–143
  24. Seppanen K, Laatikainen R, Salonen JT, Kantola M, Lotjonen S, Harri M, et al. Mercury-binding capacity of organic and inorganic selenium in rat blood and liver. Biol Trace Elem Res. 1998;65:197–210
  25. Seppanen K, Kantola M, Laatikainen R, Nyyssonen K, Valkonen VP, Kaarlopp V, et al. Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J Trace Elem Med Biol. 2000;14:84–87
  26. Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340:115–126
  27. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000;28:1815–1826
  28. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955–1960
  29. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002;22:1649–1654
  30. Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev. 2003;83:1069–1112
  31. Metso S, Loimaala A, Mercuri MF, Nenonen A, Vuori I, Oja P, et al. Circulating oxidized low-density lipoprotein and common carotid artery intima–media thickness in a random sample of middle-aged men. J Biomed Sci. 2004;11:356–361
  32. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol. 2002;22:1162–1167
  33. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med. 2004;256:413–420
  34. Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR. Circulating oxidized low-density lipoprotein and its association with carotid intima–media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol. 2004;24:1492–1497
  35. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:2243–2247
  36. Fang Y-Z, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18:872–879
  37. Pinchuk I, Lichtenberg D. The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments. Prog Lipid Res. 2002;41:279–314
  38. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–1478
  39. Huang YL, Cheng SL, Lin TH. Lipid peroxidation in rats administrated with mercuric chloride. Biol Trace Elem Res. 1996;52:193–206
  40. Lin TH, Huang YL, Huang SF. Lipid peroxidation in liver of rats administrated with methyl mercuric chloride. Biol Trace Elem Res. 1996;54:33–41
  41. Gatti R, Belletti S, Uggeri J, Vettori MV, Mutti A, Scandroglio R, et al. Methylmercury cytotoxicity in PC12 cells is mediated by primary glutathione depletion independent of excess reactive oxygen species generation. Toxicology. 2004;204:175–185
  42. Sen C. Nutritional biochemistry of cellular glutathione. J Nutr Biochem. 1997;8:660–672
  43. Sener G, Sehirli AO, Ayanoglu-Dulger G. Melatonin protects against mercury(II)-induced oxidative tissue damage in rats. Pharmacol Toxicol. 2003;93:290–296
  44. Naganuma A, Koyama Y, Imura N. Behavior of methylmercury in mammalian erythrocytes. Toxicol Appl Pharmacol. 1980;54:405–410
  45. Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?. Free Radic Biol Med. 2004;37:1317–1323
  46. Gonzalvo MC, Gil F, Hernandez AF, Villanueva E, Pla A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem Biol Interact. 1997;105:169–179
  47. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci. 2000;57:1825–1835
  48. Flohe L. Glutathione peroxidase. Basic Life Sci. 1988;49:663–668
  49. Ursini F, Maiorino M, Brigelius-Flohe R, Aumann KD, Roveri A, Schomburg D, et al. Diversity of glutathione peroxidases. Methods Enzymol. 1995;252:38–53
  50. Raes M, Michiels C, Remacle J. Comparative study of the enzymatic defense systems against oxygen-derived free radicals: the key role of glutathione peroxidase. Free Radic Biol Med. 1987;3:3–7
  51. Xia YM, Hill KE, Burk RF. Effect of selenium deficiency on hydroperoxide-induced glutathione release from the isolated perfused rat heart. J Nutr. 1985;115:733–742
  52. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003;349:1605–1613
  53. Park ST, Lim KT, Chung YT, Kim SU. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology. 1996;17:37–45
  54. Welsh SO. The protective effect of vitamin E and N,N′-diphenyl-p-phenylenediamine (DPPD) against methyl mercury toxicity in the rat. J Nutr. 1979;109:1673–1681
  55. Gasso S, Cristofol RM, Selema G, Rosa R, Rodriguez-Farre E, Sanfeliu C. Antioxidant compounds and Ca(2+) pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J Neurosci Res. 2001;66:135–145
  56. Ganther HE. Interactions of vitamin E and selenium with mercury and silver. Ann N Y Acad Sci. 1980;355:212–226
  57. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18:87–98
  58. Miller DM, Lund BO, Woods JS. Reactivity of Hg(II) with superoxide: evidence for the catalytic dismutation of superoxide by Hg(II). J Biochem Toxicol. 1991;6:293–298
  59. Lund BO, Miller DM, Woods JS. Mercury-induced H2O2 production and lipid peroxidation in vitro in rat kidney mitochondria. Biochem Pharmacol. 1991;42 Suppl:S181–S187
  60. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45:2017–2024
  61. InSug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124:211–224
  62. Seppanen K, Soininen P, Salonen JT, Lotjonen S, Laatikainen R. Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper, and iron in peroxidation of low-density lipoprotein. Biol Trace Elem Res. 2004;101:117–132
  63. Sorensen N, Murata K, Budtz-Jorgensen E, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology. 1999;10:370–375
  64. Grandjean P, Murata K, Budtz-Jorgensen E, Weihe P. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr. 2004;144:169–176
  65. Oka T, Matsukura M, Okamoto M, Harada N, Kitano T, Miike T, et al. Autonomic nervous functions in fetal type Minamata disease patients: assessment of heart rate variability. Tohoku J Exp Med. 2003;198:215–221
  66. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071
  67. Lewis JB, Wataha JC, McCloud V, Lockwood PE, Messer RL, Tseng WY. Au(III), Pd(II), Ni(II), and Hg(II) alter NF kappa B signaling in THP1 monocytic cells. J Biomed Mater Res A. 2005;74:474–481
  68. Dieguez-Acuna FJ, Ellis ME, Kushleika J, Woods JS. Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity. Toxicol Appl Pharmacol. 2001;173:176–187
  69. Shumilla JA, Wetterhahn KE, Barchowsky A. Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys. 1998;349:356–362
  70. Soleo L, Vacca A, Vimercati L, Bruno S, DiLoreto M, Zocchetti C, et al. Minimal immunological effects on workers with prolonged low exposure to inorganic mercury. Occup Environ Med. 1997;54:437–442
  71. Langworth S, Elinder CG, Sundqvist KG. Minor effects of low exposure to inorganic mercury on the human immune system. Scand J Work Environ Health. 1993;19:405–413
  72. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705–4708
  73. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol. 1995;57:737–769
  74. Kim SH, Johnson VJ, Sharma RP. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and P38 MAPK signaling pathways. Nitric Oxide. 2002;7:67–74
  75. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141–1146
  76. Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20:2039–2044
  77. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358:2127–2128
  78. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113–2117
  79. Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A. 2002;99:13527–13532
  80. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976;295:369–377
  81. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med. 1976;295:420–425
  82. Reidy MA, Schwartz SM. Endothelial regeneration: III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest. 1981;44:301–308
  83. Wong MK, Gotlieb AI. In vitro reendothelialization of a single-cell wound. Role of microfilament bundles in rapid lamellipodia-mediated wound closure. Lab Invest. 1984;51:75–81
  84. Kishimoto T, Oguri T, Abe M, Kajitani H, Tada M. Inhibitory effect of methylmercury on migration and tube formation by cultured human vascular endothelial cells. Arch Toxicol. 1995;69:357–361
  85. Kumar SV, Bose R, Bhattacharya S. Low doses of heavy metals disrupt normal structure and function of rat platelets. J Environ Pathol Toxicol Oncol. 2001;20:65–75
  86. Kumar SV, Maitra S, Bhattacharya S. In vitro binding of inorganic mercury to the plasma membrane of rat platelet affects Na+–K+-ATPase activity and platelet aggregation. Biometals. 2002;15:51–57
  87. Kumar SV, Bhattacharya S. In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: influence of adenylate cyclase and phosphodiesterase activity. In Vitro Mol Toxicol. 2000;13:137–144
  88. Wierzbicki R, Prazanowski M, Michalska M, Krajewska U, Mielicki WP. Disorders in blood coagulation in humans occupationally exposed to mercuric vapors. J Trace Elem Exp Med. 2002;15:21–29
  89. Hisatome I, Kurata Y, Sasaki N, Morisaki T, Morisaki H, Tanaka Y, et al. Block of sodium channels by divalent mercury: role of specific cysteinyl residues in the p-loop region. Biophys J. 2000;79:1336–1345
  90. Kurata Y, Hisatome I, Tsuboi M, Uenishi H, Zhang G, Oyaizu M, et al. Effect of sulfhydryl oxidoreduction on permeability of cardiac tetrodotoxin-insensitive sodium channel. Life Sci. 1998;63:1023–1035
  91. Cohen JT, Bellinger DC, Connor WE, Kris-Etherton PM, Lawrence RS, Savitz DA, et al. A quantitative risk–benefit analysis of changes in population fish consumption. Am J Prev Med. 2005;29:325–334
  92. Oken E, Kleinman KP, Berland WE, Simon SR, Rich-Edwards JW, Gillman MW. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol. 2003;102:346–351

☆ All listed authors contributed to this work, and all authors agreed to submit this manuscript to the Journal of Nutritional Biochemistry. No part of this work has been published before, except in abstract form, and all human and animal studies have been reviewed by the appropriate ethics committees.

☆☆ This work was supported by the Finnish Cultural Foundation and the Yrjö Jahnsson Foundation (for J.K. Virtanen).

PII: S0955-2863(06)00100-8

doi: 10.1016/j.jnutbio.2006.05.001

The Journal of Nutritional Biochemistry
Volume 18, Issue 2 , Pages 75-85 , February 2007

Article Tools